Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 22;11(12):e0166045.
doi: 10.1371/journal.pone.0166045. eCollection 2016.

Nanoparticle Tracking Analysis for the Enumeration and Characterization of Mineralo-Organic Nanoparticles in Feline Urine

Affiliations

Nanoparticle Tracking Analysis for the Enumeration and Characterization of Mineralo-Organic Nanoparticles in Feline Urine

M Mellema et al. PLoS One. .

Abstract

Urinary stone disease, particularly calcium oxalate, is common in both humans and cats. Calcifying nanoparticles (CNP) are spherical nanocrystallite material, and are composed of proteins (fetuin, albumin) and inorganic minerals. CNP are suggested to play a role in a wide array of pathologic mineralization syndromes including urolithiasis. We documented the development of a clinically relevant protocol to assess urinary CNP in 9 healthy cats consuming the same diet in a controlled environment using Nanoparticle Tracking Analysis (NTA®). NTA® is a novel method that allows for characterization of the CNP in an efficient, accurate method that can differentiate these particles from other urinary submicron particulates. The predominant nanoscale particles in feline urine are characteristic of CNP in terms of their size, their ability to spontaneously form under suitable conditions, and the presence of an outer layer that is rich in calcium and capable of binding to hydroxyapatite binders such as alendronate and osteopontin. The expansion of this particle population can be suppressed by the addition of citrate to urine samples. Further, compounds targeting exosomal surfaces do not label these particulates. As CNP have been associated with a number of significant urologic maladies, the method described herein may prove to be a useful adjunct in evaluating lithogenesis risk in mammals.

PubMed Disclaimer

Conflict of interest statement

Dr. Yann Queau, an employee of Royal Canin, was a coauthor of this study. Royal Canin provided no salary support for any of the authors. Royal Canin provided a grant/contract for us (MM, JLW, JAL) to purchase the NTA equipment used to analyze the urine samples we obtained from the cats in this study. Dr. Queau did not participate in study design, but did help review and edit the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. Representative histogram showing size distribution and cumulative percentage (left) of submicron particulate matter in urine from healthy cats.
A representative frame from the captured video analyzed by NTA is shown as well (right).
Fig 2
Fig 2. Fluo-4-AM positive particulate matter from a healthy cat.
A representative histogram showing averaged sizing and relative abundance data (with SE in red) and individual analyses from the triplicate assessment (right) cumulative percentage (left) of submicron particulate matter in healthy feline urine.
Fig 3
Fig 3. Representative histogram showing size distribution and cumulative percentage (left) of submicron particulate matter from urine obtained from a healthy cat.
After a 4 hr incubation at 37 deg C. A representative frame from the captured video analyzed by NTA is shown as well (right).
Fig 4
Fig 4
A: Representative histogram showing size distribution and cumulative percentage (left) of submicron particulate matter in healthy feline urine after labeling with DyLight 488 conjugated alendronate. A representative frame from the captured video analyzed by NTA is shown as well (right). Note the strongly preferential binding to primary CNP that lack an outer layer of protein or mucus. B: Representative histogram showing averaged sizing and relative abundance data (left; SE in red) and individual analyses from the assessment (right) of this representative sample of healthy feline urine after labeling with DyLight 488 conjugated osteopontin. Note the strongly preferential binding to primary naturally-occurring CNP that lack an outer layer of protein or mucus.
Fig 5
Fig 5. DyLight488-conjugated alendronate binding of CNP generated in vitro.
A representative histogram showing averaged sizing and relative abundance data (left; SE in red) and individual analyses from the assessment (right) of this representative sample in triplicate. Note that CNP generated in vitro do not acquire the protein/mucus coating known to occur in vivo and the larger forms retain the ability to bind to alendronate.
Fig 6
Fig 6. Transmission electron microscopy (TEM) images of calcifying nanoparticles (CNP).
(A) CNP synthesized de novo in the laboratory using supersatured solutions of calcium and phosphorus and a solution of bovine fetuin A (see detailed description in the methodology section). (B) CNP identified in the urine of healthy, colony cats. In each case 5 microliters of samples were applied to a coated copper mesh and excess fluid wicked away. After complete air-drying, each prepared mesh was evaluated with electron microscopy at 80KV.

References

    1. Trinchieri A. Epidemiology of urolithiasis. Archivio italiano di urologia, andrologia: organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica / Associazione Ricerche in Urologia. 1996. September;68(4):203–49. - PubMed
    1. Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. European Urology. 2003. December;44(6):709–13. - PubMed
    1. Stamatelou KK, Francis ME, Jones CA, Nyberg LM, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–1994. Kidney International. 2003. May;63(5):1817–23. 10.1046/j.1523-1755.2003.00917.x - DOI - PubMed
    1. Cannon AB, Westropp JL, Ruby AL, Kass PH. Evaluation of trends in urolith composition in cats: 5,230 cases (1985–2004). Journal of the American Veterinary Medical Association. 2007. August 15;231(4):570–6. 10.2460/javma.231.4.570 - DOI - PubMed
    1. Lieske JC, Rule AD, Krambeck AE, Williams JC, Bergstralh EJ, Mehta RA, et al. Stone composition as a function of age and sex. Clinical Journal of the American Society of Nephrology: CJASN. 2014. December 5;9(12):2141–6. Pubmed Central PMCID: 4255407. 10.2215/CJN.05660614 - DOI - PMC - PubMed